---
title: Glucose in Dialysis Water in Non-diabetics
nct_id: NCT00439023
overall_status: COMPLETED
phase: PHASE4
sponsor: Regional Hospital Holstebro
study_type: INTERVENTIONAL
primary_condition: Renal Failure, Chronic
countries: Denmark
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00439023.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00439023"
ct_last_update_post_date: 2015-09-15
last_seen_at: "2026-05-12T06:57:22.913Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Glucose in Dialysis Water in Non-diabetics

**Official Title:** Effect of Glucose in Dialysis Water on Blood Pressure and Vasoactive Hormones in Dialysis Patients

**NCT ID:** [NCT00439023](https://clinicaltrials.gov/study/NCT00439023)

## Key Facts

- **Status:** COMPLETED
- **Phase:** PHASE4
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 18
- **Lead Sponsor:** Regional Hospital Holstebro
- **Conditions:** Renal Failure, Chronic
- **Start Date:** 2006-05
- **Completion Date:** 2007-05
- **CT.gov Last Update:** 2015-09-15

## Brief Summary

The purposes are

1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and
2. to analysis the relationship between changes in blood pressure on the one hand and changes in vasoactive hormones on the other

## Detailed Description

Measurement of hormones and blood pressure during dialysis treatment.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

1. Age \> 18 years,
2. Both men and women,
3. Dialysis treatment for at least three months

Exclusion Criteria:

1. Heart failure,
2. Chronic liver disease,
3. Diabetes mellitus,
4. Malignant disease,
5. Nephrotic syndrome,
6. Lack of compliance, 7 Unwillingness to participate
```

## Interventions

- **dialysis with glucose in dialysis water** (PROCEDURE)

## Primary Outcomes

- **Effect of glucose in dialysis water on blood pressure, insulin and vasoactive hormones** _(time frame: one week)_

## Secondary Outcomes

- **Relationship between changes in blood pressure and changes in hormones during treatment** _(time frame: one week)_

## Locations (1)

- Holstebro Hospital, Holstebro, Denmark

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.holstebro hospital|holstebro||denmark` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00439023.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00439023*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*